PACS Group, Inc.
PACS stock rose 3.3% premarket after announcing two growth initiatives: acquiring 32 Florida nursing facilities and closing 11 more from the Eduro Healthcare deal, expanding its network to 355 buildings. The company's stock has recovered from a 52-week low of $7.50, now trading at $43.52. PACS's low leverage and favorable Medicare reimbursements support its growth strategy.
PACS Group (NYSE:PACS) shares rose 3.3% premarket after announcing plans to acquire 32 Florida skilled nursing facilities, adding 4,049 beds. The deal, expected to close Q4, expands PACS's southern footprint. Additionally, PACS completed closings on 11 more Eduro Healthcare facilities, bringing total Eduro closings to 31 of 34. The company now operates 355 facilities across 7 states. CEO Jason Murray highlighted Florida's growth potential.
Conway Patrick Hugh sold 3,497 shares of PACS Group, Inc. (PACS) at $44.41 ($0.16M total) on 2026-08-14.
Over the past 7 days, alphai's AI scored 2 news stories mentioning PACS (PACS Group, Inc.). Coverage has skewed bullish: 2 bullish, 0 neutral, and 0 bearish.
Recent PACS coverage spans insider activity, mergers & acquisitions and financial news.
In the last 30 days, PACS insiders filed 12 SEC Form 4 transactions — no purchases and 12 sales ($19.0M). The most active reporter was Murray Jason Hulse, Co-Founder, CEO & Chairman, with 9 filings. 92% of those filings were made under pre-arranged Rule 10b5-1 plans.
The acquisitions increase PACS' market footprint and leverage low net debt, likely supporting further share price upside.
The acquisitions increase PACS' footprint and bed count, likely supporting revenue growth.
Insider sale by a director may signal reduced confidence, potentially pressuring the stock short-term.
Large insider sell may signal reduced confidence, potentially pressuring the stock.
Pre‑planned sell likely neutral to price.
alphai scores every news story that mentions PACS with an AI model for sentiment and relevance, and aggregates insider trades from PACS Group, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
PACS stock rose 3.3% premarket after announcing two growth initiatives: acquiring 32 Florida nursing facilities and closing 11 more from the Eduro Healthcare deal, expanding its network to 355 buildings. The company's stock has recovered from a 52-week low of $7.50, now trading at $43.52. PACS's low leverage and favorable Medicare reimbursements support its growth strategy.
2 min readPACS Group (NYSE:PACS) shares rose 3.3% premarket after announcing plans to acquire 32 Florida skilled nursing facilities, adding 4,049 beds. The deal, expected to close Q4, expands PACS's southern footprint. Additionally, PACS completed closings on 11 more Eduro Healthcare facilities, bringing total Eduro closings to 31 of 34. The company now operates 355 facilities across 7 states. CEO Jason Murray highlighted Florida's growth potential.
2 min readConway Patrick Hugh sold 3,497 shares of PACS Group, Inc. (PACS) at $44.41 ($0.16M total) on 2026-08-14.
1 min readMurray Jason Hulse (Co-Founder, CEO & Chairman) sold 150,550 shares of PACS Group, Inc. (PACS) at an average of $43.92 ($43.61–$44.76, $6.61M total) across 4 trades over 2026-08-20 to 2026-08-21 under a Rule 10b5-1 trading plan.
1 min readOn Wednesday, notable insider trading activity occurred in U.S. stocks. Zentalis Pharmaceuticals (ZLAB) saw a major purchase by Walters Group, while Bakkt (BKKT), Universal Safety Products (UNSP), Advanced Flower Capital (AFCG), and Brilliant Earth (BID) also had significant insider buys. Astera Labs (ALAB), Adaptive Biotechnologies (ADPT), and PACS Group (PACS) reported insider sales, some mandatory for tax purposes. InvestingPro analysis suggests some stocks are undervalued or overvalued.
3 min readMurray Jason Hulse (Co-Founder, CEO & Chairman) sold 236,116 shares of PACS Group, Inc. (PACS) at an average of $44.20 ($43.34–$44.85, $10.44M total) across 5 trades over 2026-08-17 to 2026-08-19 under a Rule 10b5-1 trading plan.
1 min readJergensen Joshua (President & COO) sold 40,000 shares of PACS Group, Inc. (PACS) at an average of $45.59 ($44.53–$45.70, $1.82M total) across 2 trades on 2026-08-12 under a Rule 10b5-1 trading plan.
2 min readPACS Group, Inc. (PACS) filed an SEC Form 8-K — Results of Operations and Financial Condition. PACS Group, Inc. Reports Second Quarter 2026 Results Conference Call and Webcast Scheduled for Tomorrow, August 5, 2026, at 11:30 am ET. SALT LAKE CITY, Utah, August 4, 2026 – PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of
6 min readJergensen Joshua (President & COO) sold 40,000 shares of PACS Group, Inc. (PACS) at an average of $45.02 ($44.50–$45.76, $1.80M total) across 3 trades on 2026-07-15 under a Rule 10b5-1 trading plan.
2 min readHancock Mark sold 13,628 shares of PACS Group, Inc. (PACS) at an average of $45.04 ($45.04–$45.05, $0.61M total) across 2 trades over 2026-07-14 to 2026-07-15 under a Rule 10b5-1 trading plan.
1 min read